Metro-Minnesota Community Clinical Oncology Program

明尼苏达都会区社区临床肿瘤学计划

• 批准号: 7891945
• 负责人: Patrick James Flynn
• 金额: $ 238.33万
• 依托单位: PARK NICOLLET INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7891945
• 关键词: Award; Awareness; Back; Cancer Control; Cancer Patient; Chemoprevention; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Clinics and Hospitals; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Community Physician; Comprehensive Cancer Center of Wake Forest University; Eastern Cooperative Oncology Group; Enrollment; Environment; Family Practice; Funding; Goals; Grant; Growth; Gynecologic Oncology; Gynecologic Oncology Group; Health; Health Care Reform; Health Professional; Hematology; Hospital Administration; Hospitals; Improve Access; Institutes; Institution; Internal Medicine; Link; Malignant Neoplasms; Marketing; Medical; Minnesota; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Neurology; North Central Cancer Treatment Group; Oncologist; Operations Research; Operative Surgical Procedures; Participant; Patients; Primary Care Physician; Protocols documentation; Quality of life; Radiation; Radiation Therapy Oncology Group; Recording of previous events; Research; Research Design; Research Ethics Committees; Research Personnel; Specialist; Surgical Oncology; System; Thoracic Surgical Procedures; Time; Underrepresented Minority; Urology; base; cancer care; cancer prevention; cancer therapy; data management; follow-up; member; oncology; programs; research study; success; symptom management

DESCRIPTION (provided by applicant): The Metro-Minnesota Community Clinical Oncology (MMCCOP) program has a long-standing history which clearly demonstrates the success of the consortium as demonstrated by the both the ongoing commitment of the original consortium members and the growth of the consortium from 1979 through 2009. The MMCCOP consortium represents an established community program base which began in 1979 through its NCI-funded Community Hospital Cancer Program (CHCP) Award. This program would have a major impact on the way that cancer care is delivered in the community and provided the cornerstone for this CCOP initiative. This same consortium applied for and received the initial Community Clinical Oncology Program (CCOP) grant from the NCI in 1983, and has received subsequent CCOP grants since that time in 1987, 1990, 1995, and 2000 and 2005. Currently, the MMCCOP consortium represents twelve hospital and clinics with a common approach and established mechanisms for identifying, enrolling and following participants on NCI sponsored treatment, cancer prevention and cancer control protocols. The health market In the MMCCOP community remains extremely competitive and is in constant change as a result of mergers and Minnesota's healthcare reform. Despite this changing environment, the MMCCOP hospitals and associated staff continue to collaborate and support the added time and expense Involved In clinical research trials. Their level of support has not been cut back, and In fact has increased, during a time when many other projects within the hospitals are being reduced or eliminated. This program incorporates a substantial segment of the practicing physician community, and has provided a basis for communications between the practicing oncologists, their hospital administrations, and other health professionals in this consortium for the past twenty-five years. Combined, the consortium members see an average of nearly 12,000 new analytic cancer patients per year. Currently, there are 110 Investigators, representing medical, radiation and surgical oncology Including neuro-surgery, thoracic surgery and gynecologic oncology, and hematology, urology, oncology, neurology, ENT, family practice and Internal medicine. The history of MMCCOP Research Base Affiliations and proactive approach to expanding access to NCI sponsored studies supports the ability to achieve and maintain the NCI goals for the CCOP Initiative. MMCCOP intends to sustain a region wide community consortium which provides the community with the most recent advances in cancer prevention, treatment and symptom management. This will be accomplished through continued affiliations with CTSU, ECOG, NCCTG, GOG, MD Anderson, NSABP, RTOG, URCC and CCCWFU, the expansion of the current MMCCOP data management and communication system to increase the number and level of participation of the investigators In accrual, program operations and research base activities, implementation of new strategies to improve access and participation of minority and underserved groups, and increase the professional and lay community awareness of the CCOP and benefits of clinical cancer trials. In addition, all member and affiliate institutions of both Metro-MN CCOP and MN CGOP research programs are members of the Institutional Review Board for the Community Oncology Programs, administered by Park Nicollet Institute. The application is submitted as MMCCOP completes Grant Year 26 with one of most successful years since initiation of this consortium program. During the most recent NCI-Funded grant (6/05-5/09), 242 credits (235 patients) were accrued to NCI- approved treatment studies and 372.8 credits (396 new patients and follow-up of 370 participants) were accrued to approved cancer control protocols. MMCCCOP has demonstrated the ability to enter an increasing number of patients on protocol each year and proposes to accrue a total of 240 credits to Treatment studies and 350 Cancer Control credits in the first year of this award with the goal of continually exceeding the NCI requirements for both types of studies. RELEVANCE: The Metro Minnesota Community Clinical Oncology Program (MMCCOP) is a research program sponsored by the National Cancer Institute (NCI) to provide people in our community access to the newest therapy available for cancer treatment, symptom management and cancer prevention. Since Its inception in 1983, MMCCOP has linked community cancer specialists, primary care physicians and other health care professionals to the NCI-supported Cooperative Groups to conduct NCI-approved treatment, chemoprevention, symptom management and quality of life clinical trials (research studies).

描述（由申请人提供）：Metro-Minnesota Community Clinical Oncology（MMCCOP）项目有着悠久的历史，从1979年到2009年，该项目清楚地证明了联盟的成功，这一点可以从联盟原始成员的持续承诺和联盟的成长中得到证明。MMCCOP联盟代表了一个成立于1979年的社区计划基地，通过其NCI资助的社区医院癌症计划（CHCP）奖开始。该计划将对社区提供癌症护理的方式产生重大影响，并为CCOP倡议提供基石。该财团于1983年申请并获得了NCI的初始社区临床肿瘤学计划（CCOP）资助，并于1987年，1990年，1995年，2000年和2005年获得了随后的CCOP赠款。目前，MMCCOP联盟代表了12家医院和诊所，采用共同的方法和建立的机制来识别，招募和跟踪NCI赞助的治疗，癌症预防和癌症控制协议的参与者。医疗市场在MMCCOP社区仍然极具竞争力，并在不断变化的合并和明尼苏达州的医疗保健改革的结果。尽管环境不断变化，MMCCOP医院和相关工作人员继续合作，并支持临床研究试验所需的额外时间和费用。他们的支持水平并没有减少，事实上，在医院内的许多其他项目正在减少或取消的时候，他们的支持水平还在增加。该计划纳入了执业医师社区的一个重要部分，并在过去的二十五年中为执业肿瘤学家，他们的医院管理部门和该联盟中的其他卫生专业人员之间的沟通提供了基础。联合会成员每年平均看到近12，000名新的分析癌症患者。目前，有110名研究者，代表医学、放射和外科肿瘤学，包括神经外科、胸外科和妇科肿瘤学，以及血液学、泌尿科、肿瘤学、神经科、耳鼻喉科、家庭医生和内科。MMCCOP研究基地联盟的历史和扩大NCI申办研究的积极方法支持实现和维持CCOP倡议的NCI目标的能力。MMCCOP打算维持一个区域范围的社区联盟，为社区提供癌症预防、治疗和症状管理方面的最新进展。这将通过与CTSU、ECOG、NCCTG、GOG、MD安德森、NSABP、RTOG、URCC和CCCWFU的持续联系来实现，扩展当前的MMCCOP数据管理和通信系统，以增加研究者参与应计、项目运营和研究基地活动的数量和水平，实施新战略以改善少数群体和服务不足群体的访问和参与，提高专业人士和非专业人士对CCOP和临床癌症试验益处的认识。此外，Metro-MN CCOP和MN CGOP研究项目的所有成员和附属机构都是Park Nicollet Institute管理的社区肿瘤学项目机构审查委员会的成员。该申请是在MMCCOP完成第26个资助年度时提交的，这是自该联盟计划启动以来最成功的一年。在最近的NCI-Funded补助金（6/05-5/09）期间，242个学分（235名患者）被累积到NCI-approved治疗研究，372.8个学分（396名新患者和370名参与者的随访）被累积到批准的癌症控制方案。MMCCCOP已经证明了每年有能力进入越来越多的患者，并建议在该奖项的第一年累计240个治疗研究学分和350个癌症控制学分，目标是不断超过NCI对这两种类型研究的要求。 相关性：大明尼苏达州社区临床肿瘤学计划（MMCCOP）是由美国国家癌症研究所（NCI）赞助的一项研究计划，旨在为我们社区的人们提供癌症治疗，症状管理和癌症预防的最新疗法。自1983年成立以来，MMCCOP将社区癌症专家，初级保健医生和其他医疗保健专业人员与NCI支持的合作小组联系起来，进行NCI批准的治疗，化学预防，症状管理和生活质量临床试验（研究）。